Gen Digital Inc.
GENGen Digital Inc. (formerly Symantec Corporation and NortonLifeLock Inc.) is a multinational software company co-headquartered in both Tempe, Arizona (USA) and Prague, Czech Republic (EU). The company provides cybersecurity software, financial technology, and services. Gen is a Fortune 500 company and a member of the S&P 500 stock-market index. It is listed at both NASDAQ and Prague Stock Exchange. Its portfolio includes Norton, Avast, LifeLock, Avira, AVG, ReputationDefender, MoneyLion and CCleaner.
Drugs in Pipeline
4
Phase 3 Programs
3
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How GEN's past catalysts played out
Lactobacillus brevis CD2 Lozenges
Chronic Periodontitis
Probiotic
Chronic Periodontitis
Probiotic (L. brevis CD2 lozenges)
Malocclusion
GN-037
Psoriasis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Lactobacillus brevis CD2 Lozenges | Phase 3 | Chronic Periodontitis | - | - |
Probiotic | Phase 3 | Chronic Periodontitis | - | - |
Probiotic (L. brevis CD2 lozenges) | Phase 3 | Malocclusion | - | - |
GN-037 | Phase 2 | Psoriasis | - | - |
Frequently asked questions
What is in Gen Digital Inc.'s drug pipeline?→
CatalystAlert tracks 4 drug candidates in Gen Digital Inc.'s (GEN) pipeline across Phase 3, Phase 2. Its lead program is Lactobacillus brevis CD2 Lozenges (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Gen Digital Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Gen Digital Inc. (GEN) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track GEN biotech catalysts?→
Add GEN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Gen Digital Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.